News Pfizer's rituximab biosimilar gets late-stage trial boost Phase 3 success sets up showdown with Roche, Sandoz, and Celltrion
Events Partner Content BioTech Pharma Summit: Biosimilars & Biologics 2018 Biosimilars & Biologics:The future of Biotech Medicines
News Biocon and Sandoz strike biosimilars partnership Companies will develop and market several biosimilars
News Novartis files Humira biosimilar in US Novartis' Sandoz division has filed its biosimilar of Humira in the US, aiming to take a share of its multi-billion dollar revenues once its patent expires.
News Novartis tests Cosentyx against Humira and biosimilars Trials will cover psoriatic arthritis and ankylosing spondylitis
News Novo’s Ozempic among Europe’s drug recommendations Alongside the recommendation for what is set to be the first eve
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
